research

Alemtuzumab long-term immunologic effect: Treg suppressor function increases up to 24 months

Authors
Publication date
1 January 2016
Publisher
'Ovid Technologies (Wolters Kluwer Health)'
Doi
    View on PubMed

    Abstract

    To analyze changes in T-helper (Th) subsets, T-regulatory (Treg) cell percentages and function, and mRNA levels of immunologically relevant molecules during a 24-month follow-up after alemtuzumab treatment in patients with relapsing-remitting multiple sclerosis (RRMS)

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Archivio istituzionale della ricerca - Università di Cagliari

      redirect
      oaioai:iris.unica.it:11584/194240
      Last time updated on 13/04/2017

      Institutional Research Information System University of Turin

      redirect
      oaioai:iris.unito.it:2318/1564479
      Last time updated on 18/04/2020

      Crossref

      redirect
      oaiinfo:doi/10.1212%2Fnxi.0000000...
      Last time updated on 03/01/2020